Your session is about to expire
← Back to Search
High Dose Steroids for Inflammatory Bowel Disease (IBDIR Trial)
IBDIR Trial Summary
This trial will examine if delivering high dose steroids directly to inflamed bowel will help treat uncontrolled flares of inflammatory bowel disease in pediatric patients.
IBDIR Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowIBDIR Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.IBDIR Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My kidneys are not working well enough for certain tests.I have been newly diagnosed with IBD or my IBD is flaring up and not controlled by first-line therapy.I experience symptoms like abdominal pain, diarrhea, or rectal bleeding.I can give consent and attend all study visits.
- Group 1: Methylprednisolone
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the scope of participants in this research endeavor?
"Affirmative. According to the data posted on clinicaltrials.gov, this medical experience is presently inviting patients to participate. It was first announced on October 6th 2022 and has seen one update since then, on October 17th 2022. The research team seeks 30 individuals from a single location for their trial."
Who is eligible to participate in this research program?
"This medical trial is searching for 30 participants aged between 4 and 25 that suffer from inflammatory bowel disease (IBD). To be eligible, these individuals must present with common IBD symptoms such as abdominal pain, loss of appetite, rectal bleeding, diarrhea or obstruction. Additionally, they need to have been referred by the GI team and agree to provide consent/assent in order to attend all subsequent study visits."
Does this clinical trial accept participants below the age of thirty?
"The parameters for inclusion in this medical trial are 4 years old to 25 years old."
Does this research endeavor have open enrollment?
"As per the information available on clinicaltrials.gov, this research initiative is still actively looking for participants to join. It was posted online initially on October 6th 2022 and has seen its last update take place on October 17th of that same year."
Are there any serious risks associated with Methylprednisolone consumption?
"As this is a first-phase trial, there is minimal evidence regarding the safety and efficacy of methylprednisolone; we therefore assigned it a score of 1."
Share this study with friends
Copy Link
Messenger